R1 - Systemic thrombolysis in German stroke units: The experience from the German Stroke data bank

Journal of Neurology

Volumn 250, Issue 3, 2003, Pages 320-324

  Schenkel, J ^a   Weimar, C ^b   Knoll, T ^a   Haberl, Roman L ^a   Busse, O ^c   Hamann, G F ^d   Koennecke, H C ^e   Diener, H C ^b  

^a Krankenhaus Harlaching   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c KLINIKUM MINDEN   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

Cerebral ischemia; Outcome; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CONTROLLED STUDY; DATA BASE; DISABILITY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; FUNCTIONAL ASSESSMENT; GERMANY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; RATING SCALE; STROKE; SYMPTOM; SYSTEMIC THERAPY; TELEPHONE; TREATMENT OUTCOME;

EID: 0347926093     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-1004-5     Document Type: Article

References (12)

1. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35-41
2. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA (2000) Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283:1145-1150
3. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German Stroke Data Bank. Stroke 32:2559-2566
4. Grond M, Stenzel C, Schmulling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss WD (1998) Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 29:1544-1549
5. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA (2000) Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283:1151-1158
6. Koennecke HC, Nohr R, Leistner S, Marx P (2001) Intravenous tPA for ischemic stroke. Team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke 32:1074-1078
7. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC, Jr, Lewandowski CA, Kwiatkowski TP (2000) Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 55:1649-1655
8. Ringleb PA, Bertram M, Willig V, Hacke W (1999) Systemische Thrombolysetherapie mit rt-PA beim akuten Mediaterritorialinfarkt. Erfahrungen aus der klinischen Routine. Nervenarzt 70:330-334
9. Schmulling S, Grond M, Rudolf J, Heiss WD (2000) One-year follow-up in acute stroke patients treated with rtPA in clinical routine. Stroke 31:1552-1554
10. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995) N Engl J Med 333:1581-1587
11. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604-607
12. von Kummer R (2002) Brain Hemorrhage After Thrombolysis: Good or Bad? Stroke 33:1446-1447